33084343|t|In Vitro and In Vivo Comparison of Curcumin-Encapsulated Chitosan-Coated Poly(lactic-co-glycolic acid) Nanoparticles and Curcumin/Hydroxypropyl-beta-Cyclodextrin Inclusion Complexes Administered Intranasally as Therapeutic Strategies for Alzheimer's Disease.
33084343|a|Curcumin (CUR) has antioxidant and anti-inflammatory effects that are beneficial to Alzheimer's disease (AD). However, the poor solubility and high instability of CUR compromise its application greatly. In this study, CUR-encapsulated chitosan-coated poly (lactic-co-glycolic acid) nanoparticles (CUR-CS-PLGA-NPs) and hydroxypropyl-beta-cyclodextrin-encapsulated CUR complexes (CUR/HP-beta-CD inclusion complexes) were developed and compared through intranasal administration. In vitro studies indicated that CUR in CUR/HP-beta-CD inclusion complexes was stable under physiological conditions over 72 h with 95.41 +- 0.01% remaining, which was higher than 49.66 +- 3.91% remaining in CUR-CS-PLGA-NPs. Meanwhile, CUR/HP-beta-CD inclusion complexes showed a higher cellular uptake level of CUR than CUR-CS-PLGA-NPs in SH-SY5Y cells. Both formulations could reduce CUR's cellular cytotoxicity and showed a comparable antioxidant effect. Both formulations displayed the anti-inflammatory effect at 20 muM CUR in BV-2 cells, which decreased TNF-alpha and IL-6 levels to approximately 70 and 40%, respectively, when compared to the positive control, respectively. In vivo pharmacokinetic studies indicated that after intranasal administration, the AUC values of CUR in the plasma and brain of the CUR/HP-beta-CD inclusion complex group were 2.57-fold and 1.12-fold higher than those in the CUR-CS-PLGA-NP group at the same dose of 2 mg/kg, respectively. In conclusion, CUR/HP-beta-CD inclusion complexes displayed better properties than CUR-CS-PLGA-NPs as a carrier for intranasal delivery of CUR for application in AD.
33084343	35	43	Curcumin	Chemical	MESH:D003474
33084343	57	102	Chitosan-Coated Poly(lactic-co-glycolic acid)	Chemical	-
33084343	121	129	Curcumin	Chemical	MESH:D003474
33084343	130	161	Hydroxypropyl-beta-Cyclodextrin	Chemical	MESH:D000073738
33084343	238	257	Alzheimer's Disease	Disease	MESH:D000544
33084343	259	267	Curcumin	Chemical	MESH:D003474
33084343	269	272	CUR	Chemical	MESH:D003474
33084343	299	311	inflammatory	Disease	MESH:D007249
33084343	343	362	Alzheimer's disease	Disease	MESH:D000544
33084343	364	366	AD	Disease	MESH:D000544
33084343	422	425	CUR	Chemical	MESH:D003474
33084343	477	480	CUR	Chemical	MESH:D003474
33084343	494	502	chitosan	Chemical	MESH:D048271
33084343	510	540	poly (lactic-co-glycolic acid)	Chemical	MESH:D000077182
33084343	556	567	CUR-CS-PLGA	Chemical	-
33084343	577	608	hydroxypropyl-beta-cyclodextrin	Chemical	MESH:D000073738
33084343	622	625	CUR	Chemical	MESH:D003474
33084343	637	640	CUR	Chemical	MESH:D003474
33084343	641	651	HP-beta-CD	Chemical	MESH:D000073738
33084343	768	771	CUR	Chemical	MESH:D003474
33084343	775	778	CUR	Chemical	MESH:D003474
33084343	779	789	HP-beta-CD	Chemical	MESH:D000073738
33084343	943	954	CUR-CS-PLGA	Chemical	-
33084343	971	974	CUR	Chemical	MESH:D003474
33084343	975	985	HP-beta-CD	Chemical	MESH:D000073738
33084343	1047	1050	CUR	Chemical	MESH:D003474
33084343	1056	1067	CUR-CS-PLGA	Chemical	-
33084343	1075	1082	SH-SY5Y	CellLine	CVCL:0019
33084343	1121	1124	CUR	Chemical	MESH:D003474
33084343	1136	1148	cytotoxicity	Disease	MESH:D064420
33084343	1230	1242	inflammatory	Disease	MESH:D007249
33084343	1260	1263	CUR	Chemical	MESH:D003474
33084343	1267	1271	BV-2	CellLine	CVCL:0182
33084343	1295	1304	TNF-alpha	Gene	21926
33084343	1309	1313	IL-6	Gene	16193
33084343	1515	1518	CUR	Chemical	MESH:D003474
33084343	1550	1553	CUR	Chemical	MESH:D003474
33084343	1554	1564	HP-beta-CD	Chemical	MESH:D000073738
33084343	1643	1655	CUR-CS-PLGA-	Chemical	-
33084343	1722	1725	CUR	Chemical	MESH:D003474
33084343	1726	1736	HP-beta-CD	Chemical	MESH:D000073738
33084343	1790	1801	CUR-CS-PLGA	Chemical	-
33084343	1846	1849	CUR	Chemical	MESH:D003474
33084343	1869	1871	AD	Disease	MESH:D000544
33084343	Negative_Correlation	MESH:D003474	MESH:D000544
33084343	Cotreatment	MESH:D000073738	MESH:D003474
33084343	Negative_Correlation	MESH:D003474	MESH:D007249
33084343	Association	MESH:D003474	MESH:D048271
33084343	Negative_Correlation	MESH:D003474	21926
33084343	Association	MESH:D000077182	MESH:D048271
33084343	Negative_Correlation	MESH:D003474	16193
33084343	Negative_Correlation	MESH:D000073738	MESH:D000544

